Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2018

Open Access 01-12-2018 | Research article

Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors

Authors: Perrine Soret, Marta Avalos, Linda Wittkop, Daniel Commenges, Rodolphe Thiébaut

Published in: BMC Medical Research Methodology | Issue 1/2018

Login to get access

Abstract

Background

Biological assays for the quantification of markers may suffer from a lack of sensitivity and thus from an analytical detection limit. This is the case of human immunodeficiency virus (HIV) viral load. Below this threshold the exact value is unknown and values are consequently left-censored. Statistical methods have been proposed to deal with left-censoring but few are adapted in the context of high-dimensional data.

Methods

We propose to reverse the Buckley-James least squares algorithm to handle left-censored data enhanced with a Lasso regularization to accommodate high-dimensional predictors. We present a Lasso-regularized Buckley-James least squares method with both non-parametric imputation using Kaplan-Meier and parametric imputation based on the Gaussian distribution, which is typically assumed for HIV viral load data after logarithmic transformation. Cross-validation for parameter-tuning is based on an appropriate loss function that takes into account the different contributions of censored and uncensored observations. We specify how these techniques can be easily implemented using available R packages. The Lasso-regularized Buckley-James least square method was compared to simple imputation strategies to predict the response to antiretroviral therapy measured by HIV viral load according to the HIV genotypic mutations. We used a dataset composed of several clinical trials and cohorts from the Forum for Collaborative HIV Research (HIV Med. 2008;7:27-40). The proposed methods were also assessed on simulated data mimicking the observed data.

Results

Approaches accounting for left-censoring outperformed simple imputation methods in a high-dimensional setting. The Gaussian Buckley-James method with cross-validation based on the appropriate loss function showed the lowest prediction error on simulated data and, using real data, the most valid results according to the current literature on HIV mutations.

Conclusions

The proposed approach deals with high-dimensional predictors and left-censored outcomes and has shown its interest for predicting HIV viral load according to HIV mutations.
Literature
1.
go back to reference Paxton W, Coombs R, McElrath M, Keefer M, Hughes J, Sinangil F, Chernoff D, Demeter L, B BW, Corey L. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1997; 175(2):247–54.PubMedCrossRef Paxton W, Coombs R, McElrath M, Keefer M, Hughes J, Sinangil F, Chernoff D, Demeter L, B BW, Corey L. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1997; 175(2):247–54.PubMedCrossRef
2.
go back to reference Helsel DR. More than obvious: Better methods for interpreting nondetect data. Environ Sci Technol. 2005; 39(20):419–23.CrossRef Helsel DR. More than obvious: Better methods for interpreting nondetect data. Environ Sci Technol. 2005; 39(20):419–23.CrossRef
3.
go back to reference Lee M, Kong L, Weissfeld L. Multiple imputation for left-censored biomarker data based on Gibbs sampling method. Stat Med. 2012; 31:1838–48.PubMedCrossRef Lee M, Kong L, Weissfeld L. Multiple imputation for left-censored biomarker data based on Gibbs sampling method. Stat Med. 2012; 31:1838–48.PubMedCrossRef
4.
go back to reference Del Greco M F, Pattaro C, Minelli C, Thompson JR. Bayesian analysis of censored response data in family-based genetic association studies. Biom J. 2016; 58(5):1039–53.PubMedCrossRef Del Greco M F, Pattaro C, Minelli C, Thompson JR. Bayesian analysis of censored response data in family-based genetic association studies. Biom J. 2016; 58(5):1039–53.PubMedCrossRef
5.
go back to reference Marschner I, Betensky R, DeGruttola V, Hammer S, Kuritzkes D. Clinical trials using HIV-1 RNA-based primary endpoints: Statistical analysis and potential biase. J Acquir Immune Defic Syndr Hum Retrovirol. 1999; 20(3):220–7.PubMedCrossRef Marschner I, Betensky R, DeGruttola V, Hammer S, Kuritzkes D. Clinical trials using HIV-1 RNA-based primary endpoints: Statistical analysis and potential biase. J Acquir Immune Defic Syndr Hum Retrovirol. 1999; 20(3):220–7.PubMedCrossRef
6.
go back to reference Gillespie BW, Chen Q, Reichert H, Franzblau A, Hedgeman E, Lepkowski J, Adriaens P, Demond A, Luksemburg W, Garabrant DH. Estimating population distributions when some data are below a limit of detection by using a reverse Kaplan-Meier estimator. Epidemiology. 2010; 21:64–70.CrossRef Gillespie BW, Chen Q, Reichert H, Franzblau A, Hedgeman E, Lepkowski J, Adriaens P, Demond A, Luksemburg W, Garabrant DH. Estimating population distributions when some data are below a limit of detection by using a reverse Kaplan-Meier estimator. Epidemiology. 2010; 21:64–70.CrossRef
7.
go back to reference Dinse G, Jusko A, Ho L, Annam K, Graubard B, Hertz-Picciotto I, Miller F, Gillespie B, Weinberg C. Accomodating measurements below a limit of detection: A novel application of Cox regression. Am J Epidemiol. 2014; 179(8):1018–24.PubMedPubMedCentralCrossRef Dinse G, Jusko A, Ho L, Annam K, Graubard B, Hertz-Picciotto I, Miller F, Gillespie B, Weinberg C. Accomodating measurements below a limit of detection: A novel application of Cox regression. Am J Epidemiol. 2014; 179(8):1018–24.PubMedPubMedCentralCrossRef
8.
go back to reference Wang HJ, Zhu Z, Zhou J. Quantile regression in partially linear varying coefficient models. Ann Stat. 2009; 37(6B):3841–66.CrossRef Wang HJ, Zhu Z, Zhou J. Quantile regression in partially linear varying coefficient models. Ann Stat. 2009; 37(6B):3841–66.CrossRef
9.
go back to reference Eilers PH, Röder E, Savelkoul HF, van Wijk RG. Quantile regression for the statistical analysis of immunological data with many non-detects. BMC Immunol. 2012; 13:13–37.CrossRef Eilers PH, Röder E, Savelkoul HF, van Wijk RG. Quantile regression for the statistical analysis of immunological data with many non-detects. BMC Immunol. 2012; 13:13–37.CrossRef
10.
go back to reference Powell JL. Least absolute deviations estimation for the censored regression model. J Econ. 1984; 25:303–25.CrossRef Powell JL. Least absolute deviations estimation for the censored regression model. J Econ. 1984; 25:303–25.CrossRef
11.
12.
go back to reference Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958; 26:24–36.CrossRef Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958; 26:24–36.CrossRef
13.
go back to reference Hughes JP. Mixed effects models with censored data with application to HIV RNA levels. Biometrics. 1999; 55:625–9.PubMedCrossRef Hughes JP. Mixed effects models with censored data with application to HIV RNA levels. Biometrics. 1999; 55:625–9.PubMedCrossRef
14.
go back to reference Jacqmin-Gadda H, Thiébaut R, Chêne G, Commenges D. Analysis of left-censored longitudinal data with application to viral load in HIV infection. Biostatistics. 2000; 1(4):355–68.PubMedCrossRef Jacqmin-Gadda H, Thiébaut R, Chêne G, Commenges D. Analysis of left-censored longitudinal data with application to viral load in HIV infection. Biostatistics. 2000; 1(4):355–68.PubMedCrossRef
15.
16.
go back to reference Nie L, Chu H, Liu C, Cole SR, Vexler A, Schisterman EF. Linear regression with an independent variable subject to a detection limit. Epidemiology. 2010; 21:17–24.CrossRef Nie L, Chu H, Liu C, Cole SR, Vexler A, Schisterman EF. Linear regression with an independent variable subject to a detection limit. Epidemiology. 2010; 21:17–24.CrossRef
17.
go back to reference Fu P, Hughes J, Zeng G, Hanook S, Orem J, Mwanda O, Remick S. A comparative investigation of methods for longitudinal data with limits of detection through a case study. Stat Methods Med Res. 2016; 25(1):153–66.PubMedCrossRef Fu P, Hughes J, Zeng G, Hanook S, Orem J, Mwanda O, Remick S. A comparative investigation of methods for longitudinal data with limits of detection through a case study. Stat Methods Med Res. 2016; 25(1):153–66.PubMedCrossRef
18.
go back to reference Wiegand RE, Rose CE, Karon JM. Comparison of models for analyzing two-group, cross-sectional data with a gaussian outcome subject to a detection limit. Stat Methods Med Res. 2016; 25(6):2733–49.PubMedCrossRef Wiegand RE, Rose CE, Karon JM. Comparison of models for analyzing two-group, cross-sectional data with a gaussian outcome subject to a detection limit. Stat Methods Med Res. 2016; 25(6):2733–49.PubMedCrossRef
19.
go back to reference Buckley J, James I. Linear regression with censored data. Biometrika. 1979; 66:429–36.CrossRef Buckley J, James I. Linear regression with censored data. Biometrika. 1979; 66:429–36.CrossRef
20.
go back to reference Hewett P, Ganser GH. A comparison of several methods for analyzing censored data. Ann Occup Hyg. 2007; 51:611–32.PubMed Hewett P, Ganser GH. A comparison of several methods for analyzing censored data. Ann Occup Hyg. 2007; 51:611–32.PubMed
21.
go back to reference Uh H-W, Hartgers FC, Yazdanbakhsh M, Houwing-Duistermaat JJ. Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol. 2008; 9(1):59.PubMedPubMedCentralCrossRef Uh H-W, Hartgers FC, Yazdanbakhsh M, Houwing-Duistermaat JJ. Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol. 2008; 9(1):59.PubMedPubMedCentralCrossRef
22.
go back to reference Kafatos G, Andrews N, McConway KJ, Farrington P. Regression models for censored serological data. J Med Microbiol. 2013; 62(Pt 1):93–100.PubMedCrossRef Kafatos G, Andrews N, McConway KJ, Farrington P. Regression models for censored serological data. J Med Microbiol. 2013; 62(Pt 1):93–100.PubMedCrossRef
23.
go back to reference Hirsch MS, Günthard HF, Schapiro JM, Vézinet FB, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008; 47(2):266–85.PubMedCrossRef Hirsch MS, Günthard HF, Schapiro JM, Vézinet FB, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008; 47(2):266–85.PubMedCrossRef
24.
go back to reference Wittkop L, Günthard H, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, Garcia F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem A, Colin C, Kjaer J, Lundgren J, Paredes R, Pozniak A, Clotet B, philipps A, Pillay D, Chêne G, study group E-C. Effects of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (euro-coord-chain joint project): a european multicohort study. Lancet Infect Dis. 2011; 11(5):363–71.PubMedCrossRef Wittkop L, Günthard H, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, Garcia F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem A, Colin C, Kjaer J, Lundgren J, Paredes R, Pozniak A, Clotet B, philipps A, Pillay D, Chêne G, study group E-C. Effects of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (euro-coord-chain joint project): a european multicohort study. Lancet Infect Dis. 2011; 11(5):363–71.PubMedCrossRef
25.
go back to reference Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in europe. Clin Infect Dis. 2016; 62(5):655–63.PubMedCrossRef Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in europe. Clin Infect Dis. 2016; 62(5):655–63.PubMedCrossRef
26.
go back to reference Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. 2017 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2017; 24(4):132. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. 2017 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2017; 24(4):132.
27.
go back to reference Rabinowitz M, Myers L, Banjevic M, Chan A, Sweetkind-Singer J, Haberer J, McCann K, Wolkowicz R. Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization. Bioinformatics. 2006; 22(5):541–9.PubMedCrossRef Rabinowitz M, Myers L, Banjevic M, Chan A, Sweetkind-Singer J, Haberer J, McCann K, Wolkowicz R. Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization. Bioinformatics. 2006; 22(5):541–9.PubMedCrossRef
28.
go back to reference Beerenwinkel N, Montazeri H, Schuhmacher H, Knupfer P, von Wyl V, Furrer H, Battegay M, Hirschel B, Cavassini M, Vernazza P, Bernasconi E, Yerly S, Böni J, Klimkait T, Cellerai C, Günthard HF, Study TSHC. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients. PLoS Comput Biol. 2013; 9(8):1–11.CrossRef Beerenwinkel N, Montazeri H, Schuhmacher H, Knupfer P, von Wyl V, Furrer H, Battegay M, Hirschel B, Cavassini M, Vernazza P, Bernasconi E, Yerly S, Böni J, Klimkait T, Cellerai C, Günthard HF, Study TSHC. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients. PLoS Comput Biol. 2013; 9(8):1–11.CrossRef
29.
go back to reference Cozzi-Lepri A, Prosperi MCF, Kjær J, Dunn D, Paredes R, Sabin CA, Lundgren JD, Phillips AN, Pillay D, for the EuroSIDA, the United Kingdom CHIC/United Kingdom HDRD Studies. Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? an application to derive a lopinavir-score. PLoS ONE. 2011; 6(11):1–9.CrossRef Cozzi-Lepri A, Prosperi MCF, Kjær J, Dunn D, Paredes R, Sabin CA, Lundgren JD, Phillips AN, Pillay D, for the EuroSIDA, the United Kingdom CHIC/United Kingdom HDRD Studies. Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? an application to derive a lopinavir-score. PLoS ONE. 2011; 6(11):1–9.CrossRef
30.
go back to reference Wittkop L, Commenges D, Pellegrin I, Breilh D, Neau D, Lacoste D, Pellegrin J-L, Chêne G, Dabis F, Thiébaut R. Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy. BMC Med Res Methodol. 2008; 8(1):68.PubMedPubMedCentralCrossRef Wittkop L, Commenges D, Pellegrin I, Breilh D, Neau D, Lacoste D, Pellegrin J-L, Chêne G, Dabis F, Thiébaut R. Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy. BMC Med Res Methodol. 2008; 8(1):68.PubMedPubMedCentralCrossRef
31.
go back to reference Assoumou L, Houssaïna A, Corstagliola D, Flandre P, Standardization and clinical relevance of HIV drug resistance testing project from the forum for collaborative HIV research. Relative contributions of baseline patient characteristics and the choice of statistical methods to the variability of genotypic resistance scores: the example of didanosine. J Antimicrop Chemother. 2010; 65(4):752–60.CrossRef Assoumou L, Houssaïna A, Corstagliola D, Flandre P, Standardization and clinical relevance of HIV drug resistance testing project from the forum for collaborative HIV research. Relative contributions of baseline patient characteristics and the choice of statistical methods to the variability of genotypic resistance scores: the example of didanosine. J Antimicrop Chemother. 2010; 65(4):752–60.CrossRef
32.
go back to reference Rhee S, Taylor J, Wadhera G, Ben-Hur A, Brutlag D, Shafer R. Genotypic predictos of human immunodeficiency cirus type 1 drug resistance. Proc Natl Acad Sci USA. 2006; 103(46):17355–60.PubMedCrossRefPubMedCentral Rhee S, Taylor J, Wadhera G, Ben-Hur A, Brutlag D, Shafer R. Genotypic predictos of human immunodeficiency cirus type 1 drug resistance. Proc Natl Acad Sci USA. 2006; 103(46):17355–60.PubMedCrossRefPubMedCentral
33.
go back to reference Tibshirani R. The Lasso method for variable selection in the Cox model. Stat Med. 1997; 16:385–95.PubMedCrossRef Tibshirani R. The Lasso method for variable selection in the Cox model. Stat Med. 1997; 16:385–95.PubMedCrossRef
34.
go back to reference Huang J, Ma S, Xie H. Regularized estimation in the accelerated failure time model with high-dimensional covariates. Biometrics. 2006; 62:813–20.PubMedCrossRef Huang J, Ma S, Xie H. Regularized estimation in the accelerated failure time model with high-dimensional covariates. Biometrics. 2006; 62:813–20.PubMedCrossRef
35.
go back to reference Datta S, Le-Rademacher J, Datta S. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and Lasso. Biometrics. 2007; 63:259–71.PubMedCrossRef Datta S, Le-Rademacher J, Datta S. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and Lasso. Biometrics. 2007; 63:259–71.PubMedCrossRef
36.
go back to reference Johnson BA. Variable selection in semiparametric linear regression with censored data. J R Stat Soc Ser B Stat Methodol. 2008; 70:351–70.CrossRef Johnson BA. Variable selection in semiparametric linear regression with censored data. J R Stat Soc Ser B Stat Methodol. 2008; 70:351–70.CrossRef
37.
go back to reference Wang S, Nan B, Zhu J, Beer DG. Doubly penalized Buckley-James method for survival data with high-dimensional covariates. Biometrics. 2008; 64(1):132–40.PubMedCrossRef Wang S, Nan B, Zhu J, Beer DG. Doubly penalized Buckley-James method for survival data with high-dimensional covariates. Biometrics. 2008; 64(1):132–40.PubMedCrossRef
39.
go back to reference Ueki M. A note on automatic variable selection using smooth-threshold estimating equations. Biometrika. 2009; 96(4):1005–11.CrossRef Ueki M. A note on automatic variable selection using smooth-threshold estimating equations. Biometrika. 2009; 96(4):1005–11.CrossRef
40.
go back to reference Wang Z, Wang CY. Buckley-james boosting for survival analysis with high-dimensional biomarker data. Stat Appl Genet Mol Biol. 2010; 9(1):24.PubMedCentral Wang Z, Wang CY. Buckley-james boosting for survival analysis with high-dimensional biomarker data. Stat Appl Genet Mol Biol. 2010; 9(1):24.PubMedCentral
41.
go back to reference Shows JH, Lu W, Zhang HH. Sparse estimation and inference for censored median regression. J Stat Plan Infer. 2010; 140:1903–17.CrossRef Shows JH, Lu W, Zhang HH. Sparse estimation and inference for censored median regression. J Stat Plan Infer. 2010; 140:1903–17.CrossRef
42.
43.
go back to reference Chung M, Long Q, Johnson BA. A tutorial on rank-based coefficient estimation for censored data in small-and large-scale problems. Stat Comput. 2013; 23(5):601–14.PubMedCrossRef Chung M, Long Q, Johnson BA. A tutorial on rank-based coefficient estimation for censored data in small-and large-scale problems. Stat Comput. 2013; 23(5):601–14.PubMedCrossRef
44.
go back to reference Huang X, Pan W, Park S, Han X, Miller LW, Hall J. Modeling the relationship between LVAD support time and gene expression changes in the human heart by penalized partial least squares. Bioinformatics. 2004; 20(6):888–94.PubMedCrossRef Huang X, Pan W, Park S, Han X, Miller LW, Hall J. Modeling the relationship between LVAD support time and gene expression changes in the human heart by penalized partial least squares. Bioinformatics. 2004; 20(6):888–94.PubMedCrossRef
45.
go back to reference Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008; 2:841–60.CrossRef Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008; 2:841–60.CrossRef
46.
go back to reference Wang Y, Chen T, Zeng D. Support vector hazards machine: A counting process framework for learning risk scores for censored outcomes. J Mach Learn Res. 2016; 17(167):1–37.PubMedPubMedCentral Wang Y, Chen T, Zeng D. Support vector hazards machine: A counting process framework for learning risk scores for censored outcomes. J Mach Learn Res. 2016; 17(167):1–37.PubMedPubMedCentral
47.
go back to reference Van der Burgh HK, Schmidt R, Westeneng H-J, de Reus MA, van den Berg LH, van den Heuvel MP. Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. NeuroImage Clin. 2017; 13:361–9.PubMedCrossRef Van der Burgh HK, Schmidt R, Westeneng H-J, de Reus MA, van den Berg LH, van den Heuvel MP. Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. NeuroImage Clin. 2017; 13:361–9.PubMedCrossRef
48.
go back to reference Johnson BA. On lasso for censored data. Electron J Stat. 2009; 3:485–506.CrossRef Johnson BA. On lasso for censored data. Electron J Stat. 2009; 3:485–506.CrossRef
49.
go back to reference Cozzi-Lepri A. Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response. HIV Med. 2008; 9(1):27–40.PubMedCrossRef Cozzi-Lepri A. Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response. HIV Med. 2008; 9(1):27–40.PubMedCrossRef
50.
go back to reference Marks G, Gardner LI, Craw J, Giordano TP, Mugavero MJ, Keruly JC, Wilson TE, Metsch LR, Drainoni M-L, Malitz F. The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load?. Clin Infect Dis. 2011; 53(11):1168–9.PubMedCrossRef Marks G, Gardner LI, Craw J, Giordano TP, Mugavero MJ, Keruly JC, Wilson TE, Metsch LR, Drainoni M-L, Malitz F. The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load?. Clin Infect Dis. 2011; 53(11):1168–9.PubMedCrossRef
51.
go back to reference Dao CN, Patel P, Overton ET, Rhame F, Pals SL, Johnson C, Bush T, Brooks JT, Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis. 2011; 52(3):396–405.PubMedCrossRef Dao CN, Patel P, Overton ET, Rhame F, Pals SL, Johnson C, Bush T, Brooks JT, Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis. 2011; 52(3):396–405.PubMedCrossRef
52.
go back to reference Leon A, Perez I, Ruiz-Mateos E, Benito JM, Leal M, Lopez-Galindez C, Rallon N, Alcami J, Lopez-Aldeguer J, Viciana P, et al. Rate and predictors of progression in elite and viremic HIV-1 controllers. AIDS. 2016; 30(8):1209–20.PubMedCrossRef Leon A, Perez I, Ruiz-Mateos E, Benito JM, Leal M, Lopez-Galindez C, Rallon N, Alcami J, Lopez-Aldeguer J, Viciana P, et al. Rate and predictors of progression in elite and viremic HIV-1 controllers. AIDS. 2016; 30(8):1209–20.PubMedCrossRef
53.
go back to reference Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol. 1996; 58(1):267–88. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol. 1996; 58(1):267–88.
54.
go back to reference Sigrist F, Stahel WA. Using the censored gamma distribution for modeling fractional response variables with an application to loss given default. ASTIN Bull J Int Actuar Assoc. 2011; 41(02):673–710. Sigrist F, Stahel WA. Using the censored gamma distribution for modeling fractional response variables with an application to loss given default. ASTIN Bull J Int Actuar Assoc. 2011; 41(02):673–710.
55.
go back to reference Belloni A, Chernozhukov V. L1-penalized quantile regression in high-dimensional sparse models. Ann Stat. 2011; 39(1):82–130.CrossRef Belloni A, Chernozhukov V. L1-penalized quantile regression in high-dimensional sparse models. Ann Stat. 2011; 39(1):82–130.CrossRef
56.
go back to reference Xue X, Xie X, Strickler HD. A censored quantile regression approach for the analysis of time to event data. Stat Methods Med Res. 2018; 27(3):955–65.PubMedCrossRef Xue X, Xie X, Strickler HD. A censored quantile regression approach for the analysis of time to event data. Stat Methods Med Res. 2018; 27(3):955–65.PubMedCrossRef
57.
go back to reference Zhanfeng W, Yaohua W, Lincheng Z. A lasso-type approach to variable selection and estimation for censored regression model. Chin J Appl Probab Stat. 2010; 26(1):66–80. Zhanfeng W, Yaohua W, Lincheng Z. A lasso-type approach to variable selection and estimation for censored regression model. Chin J Appl Probab Stat. 2010; 26(1):66–80.
58.
go back to reference Yue YR, Hong HG. Bayesian tobit quantile regression model for medical expenditure panel survey data. Stat Model. 2012; 12(4):323–46.CrossRef Yue YR, Hong HG. Bayesian tobit quantile regression model for medical expenditure panel survey data. Stat Model. 2012; 12(4):323–46.CrossRef
59.
go back to reference Liu X, Wang Z, Wu Y. Group variable selection and estimation in the tobit censored response model. Comput Stat Data Anal. 2013; 60:80–9.CrossRef Liu X, Wang Z, Wu Y. Group variable selection and estimation in the tobit censored response model. Comput Stat Data Anal. 2013; 60:80–9.CrossRef
60.
go back to reference Zhou X, Liu G. LAD-lasso variable selection for doubly censored median regression models. Commun Stat Theory Methods. 2013; 45(12):3658–67.CrossRef Zhou X, Liu G. LAD-lasso variable selection for doubly censored median regression models. Commun Stat Theory Methods. 2013; 45(12):3658–67.CrossRef
61.
go back to reference Alhamzawi R. Bayesian elastic net tobit quantile regression. Commun Stat Simul Comput. 2016; 45(7):2409–27.CrossRef Alhamzawi R. Bayesian elastic net tobit quantile regression. Commun Stat Simul Comput. 2016; 45(7):2409–27.CrossRef
62.
go back to reference Müller P, van de Geer S. Censored linear model in high dimensions. TEST. 2015; 25(1):75–92.CrossRef Müller P, van de Geer S. Censored linear model in high dimensions. TEST. 2015; 25(1):75–92.CrossRef
63.
go back to reference Peter Wu C-S, Zubovic Y. A large-scale monte carlo study of the Buckley-James estimator with censored data. J Stat Comput Simul. 1995; 51(2-4):97–119.CrossRef Peter Wu C-S, Zubovic Y. A large-scale monte carlo study of the Buckley-James estimator with censored data. J Stat Comput Simul. 1995; 51(2-4):97–119.CrossRef
64.
go back to reference Wang Y-G, Zhao Y, Fu L. The Buckley–James estimator and induced smoothing. Aust N Z J Stat. 2016; 58(2):211–25.CrossRef Wang Y-G, Zhao Y, Fu L. The Buckley–James estimator and induced smoothing. Aust N Z J Stat. 2016; 58(2):211–25.CrossRef
65.
go back to reference Gleit A. Estimation for small normal data sets with detection limits. Environ Sci Technol. 1985; 19(12):1201–6.PubMedCrossRef Gleit A. Estimation for small normal data sets with detection limits. Environ Sci Technol. 1985; 19(12):1201–6.PubMedCrossRef
67.
68.
go back to reference DiRienzo AG. Parsimonious covariate selection with censored outcomes. Biometrics. 2016; 72:452–62.PubMedCrossRef DiRienzo AG. Parsimonious covariate selection with censored outcomes. Biometrics. 2016; 72:452–62.PubMedCrossRef
69.
70.
73.
go back to reference Shafer RW, Schapiro JM. HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev. 2008; 10(2):67.PubMedPubMedCentral Shafer RW, Schapiro JM. HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev. 2008; 10(2):67.PubMedPubMedCentral
74.
go back to reference Johnson VA, Brun-Vézinet F, Clotet B, Gunthard H, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med. 2009; 17(5):138–45.PubMed Johnson VA, Brun-Vézinet F, Clotet B, Gunthard H, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med. 2009; 17(5):138–45.PubMed
Metadata
Title
Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors
Authors
Perrine Soret
Marta Avalos
Linda Wittkop
Daniel Commenges
Rodolphe Thiébaut
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2018
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-018-0609-4

Other articles of this Issue 1/2018

BMC Medical Research Methodology 1/2018 Go to the issue